M
Margaret E. Rick
Researcher at National Institutes of Health
Publications - 63
Citations - 3428
Margaret E. Rick is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Von Willebrand factor & Platelet. The author has an hindex of 28, co-authored 63 publications receiving 3245 citations. Previous affiliations of Margaret E. Rick include University of Basel.
Papers
More filters
Journal ArticleDOI
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
William L. Nichols,M. B. Hultin,Andra H. James,Marilyn J. Manco-Johnson,Robert R. Montgomery,Thomas L. Ortel,Margaret E. Rick,J. E. Sadler,Milton C. Weinstein,Barbara P. Yawn +9 more
TL;DR: This document summarizes needs for further research in VWF, VWD and bleeding disorders, including clinical research to obtain more objective information about bleeding symptoms, advancements in diagnostic and therapeutic tools, and enhancement in the education and training of clinicians and scientists in bleeding and thrombotic disorders.
Journal ArticleDOI
Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome
Maryalice Stetler-Stevenson,Diane C. Arthur,Nicholas Jabbour,Xiu Y. Xie,Jeffrey J. Molldrem,A. John Barrett,David Venzon,Margaret E. Rick +7 more
TL;DR: It is concluded that flow cytometric immunophenotyping may help establish the diagnosis of MDS, especially when morphology and cytogenetics are indeterminate.
Journal ArticleDOI
High Prevalence of Osteonecrosis of the Femoral Head in HIV-Infected Adults
Kirk D. Miller,Henry Masur,Elizabeth C. Jones,Galen O. Joe,Margaret E. Rick,Grace Kelly,JoAnn M. Mican,Shuying Liu,Lynn H. Gerber,William C. Blackwelder,Judith Falloon,Richard T. Davey,Michael A. Polis,Robert E. Walker,H. Clifford Lane,Joseph A. Kovacs +15 more
TL;DR: A prospective MRI-based study to determine the prevalence of and evaluate possible risk factors for asymptomatic osteonecrosis of the hip in a sample of HIV-infected patients and hypothesized that additional patients may have developed clinically silent oste onecrosis.
Journal ArticleDOI
Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.
Jeff S. Isenberg,Martin J. Romeo,Christine Yu,Christine K. Yu,Khauh Nghiem,Jude Monsale,Margaret E. Rick,David A. Wink,William A. Frazier,David D. Roberts +9 more
TL;DR: Release of thrombospondin-1 from alpha-granules during activation provides positive feedback to promote efficient platelet aggregation and adhesion by overcoming the antithrombotic activity of physiologic NO.
Journal ArticleDOI
The Incidence and Natural History of Osteonecrosis in HIV-Infected Adults
Caryn G. Morse,JoAnn M. Mican,Elizabeth C. Jones,Galen O. Joe,Margaret E. Rick,Elizabeth Formentini,Joseph A. Kovacs +6 more
TL;DR: HIV-infected patients are at approximately 100-fold greater risk of developing osteonecrosis than the general population and disease progression is slower in asymptomatic patients than in symptomatic patients.